Seguir
Blanco-Heredia, J.
Blanco-Heredia, J.
Memorial Sloan Kettering Cancer Center, CMO Innovation Lab
Dirección de correo verificada de bsc.es - Página principal
Título
Citado por
Citado por
Año
Unique features of HLA-mediated HIV evolution in a Mexican cohort: a comparative study
S Avila-Rios, CE Ormsby, JM Carlson, H Valenzuela-Ponce, ...
Retrovirology 6, 1-23, 2009
412009
New emerging targets in cancer immunotherapy: the role of neoantigens
L De Mattos-Arruda, J Blanco-Heredia, C Aguilar-Gurrieri, J Carrillo, ...
ESMO open 4, e000684, 2019
352019
Genomic profiling reveals germline predisposition and homologous recombination deficiency in pancreatic acinar cell carcinoma
D Mandelker, A Marra, B Zheng-Lin, P Selenica, J Blanco-Heredia, Y Zhu, ...
Journal of Clinical Oncology 41 (33), 5151-5162, 2023
242023
Immune analysis of lymph nodes in relation to the presence or absence of tumor infiltrating lymphocytes in triple-negative breast cancer
Á Quintana, V Peg, A Prat, T Moliné, G Villacampa, L Paré, P Galván, ...
European Journal of Cancer 148, 134-145, 2021
192021
Adherence to a supplemented mediterranean diet drives changes in the gut microbiota of HIV-1-infected individuals
R Pastor-Ibáñez, J Blanco-Heredia, F Etcheverry, S Sánchez-Palomino, ...
Nutrients 13 (4), 1141, 2021
182021
Immune correlates of HIV control
JG Prado, J Carrillo, J Blanco-Heredia, C Brander
Current medicinal chemistry 18 (26), 3963-3970, 2011
82011
Identification of immunogenic cytotoxic T lymphocyte epitopes containing drug resistance mutations in antiretroviral treatment-naïve HIV-infected individuals
J Blanco-Heredia, A Lecanda, H Valenzuela-Ponce, C Brander, ...
PloS one 11 (1), e0147571, 2016
72016
Converging and evolving immuno-genomic routes toward immune escape in breast cancer
J Blanco-Heredia, CA Souza, JL Trincado, M Gonzalez-Cao, ...
Nature Communications 15 (1), 1302, 2024
62024
The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers
L De Mattos-Arruda, J Cortes, J Blanco-Heredia, DG Tiezzi, G Villacampa, ...
NPJ Breast Cancer 7 (1), 73, 2021
62021
Clinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity?
J Yu, EM da Silva, HS La, BZ Clark, JL Fine, GJ Carter, TM Villatoro, ...
NPJ Breast Cancer 9 (1), 60, 2023
42023
Chromothripsis-mediated small cell lung carcinoma
N Rekhtman, SE Tischfield, CA Febres-Aldana, JJK Lee, JC Chang, ...
Cancer Discovery 15 (1), 83-104, 2025
32025
Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice
A Barajas, P Amengual-Rigo, A Pons-Grífols, R Ortiz, O Gracia Carmona, ...
Journal of Translational Medicine 22 (1), 14, 2024
32024
APOBEC3 mutagenesis drives therapy resistance in breast cancer
A Gupta, A Gazzo, P Selenica, A Safonov, F Pareja, EM da Silva, ...
bioRxiv, 2024.04. 29.591453, 2024
32024
Abstract P2-23-15: Histologic, immunohistochemical and genomic comparison between classic Invasive lobular carcinomas and lobular-like invasive ductal carcinomas
EM da Silva, T Basili, J Yu, J Blanco-Heredia, P Selenica, Q Ye, AC Paula, ...
Cancer Research 83 (5_Supplement), P2-23-15-P2-23-15, 2023
12023
Molecular and microenvironmental landscapes of human papillomavirus-independent invasive squamous cell carcinoma of the vulva
S Moufarrij, O Filippova, ADC Paula, JB Heredia, H Green, V Broach, ...
International Journal of Gynecological Cancer, 100051, 2024
2024
Molecular and tumor microenvironmental characterization of HPV-negative invasive squamous cell carcinoma of the vulva
S Moufarrij, O Filippova, ADC Paula, JB Heredia, M Leitao, R O'Cearbhaill, ...
Gynecologic Oncology 190, S153-S154, 2024
2024
Abstract PO3-14-08: Metaplastic Breast Cancer: Whole Genome Sequencing Analysis and Emerging Therapeutic Targets
F Pareja, A Gazzo, H Dopeso, D Brown, P Selenica, Y Zhu, ...
Cancer Research 84 (9_Supplement), PO3-14-08-PO3-14-08, 2024
2024
2341P Novel therapeutic opportunities in metaplastic breast cancer
F Pareja, A Gazzo, H Dopeso, D Brown, P Selenica, Y Zhu, JB Heredia, ...
Annals of Oncology 34, S1193, 2023
2023
1246P Detection of alternative lengthening of telomeres (ALT) across cancer types based on tumor-normal multigene panel sequencing
JB Heredia, BH Diplas, OSM El Nahhas, P Selenica, F Pareja, ...
Annals of Oncology 34, S725-S726, 2023
2023
Abstract P1-13-17: Hyperactivation of the EGFR pathway is associated with resistance to tucatinib in HER2-positive breast cancer models
FT Liao, T Gordon, CC Liu, P Selenica, Y Zhu, J Patel, S Nanda, L Qin, ...
Cancer Research 83 (5_Supplement), P1-13-17-P1-13-17, 2023
2023
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20